Large cell calcifying Sertoli cell tumour: molecular and immunohistochemical assessment of a series comprising non‐metastasising and metastasising neoplasms
暂无分享,去创建一个
Chia‐Sui Kao | T. Ulbright | C. Fletcher | M. Colecchia | S. Wobker | A. Acosta | L. Sholl | J. Gordetsky | F. Maclean | W. Anderson | Květoslava Michalová | S. Vargas | Muhammad T. Idrees | K. Cornejo | Sanhong Yu | S. Siegmund | Katrina Collins | Maria Del Pilar Gonzalez-Peramato
[1] Danielle K. Manning,et al. Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations , 2022, Modern Pathology.
[2] J. Cheville,et al. Large cell calcifying Sertoli cell tumour: a contemporary multi‐institutional case series highlighting the diagnostic utility of PRKAR1A immunohistochemistry , 2021, Histopathology.
[3] F. Faucz,et al. Somatic PRKAR1A Gene Mutation in a Nonsyndromic Metastatic Large Cell Calcifying Sertoli Cell Tumor , 2019, Journal of the Endocrine Society.
[4] L. Macconaill,et al. Targeted Cancer Next-Generation Sequencing as a Primary Screening Tool for Microsatellite Instability and Lynch Syndrome in Upper Gastrointestinal Tract Cancers , 2019, Cancer Epidemiology, Biomarkers & Prevention.
[5] L. Macconaill,et al. Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma , 2018, Modern Pathology.
[6] L. Macconaill,et al. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer. , 2017, Archives of pathology & laboratory medicine.
[7] Marian Harris,et al. Institutional implementation of clinical tumor profiling on an unselected cancer population. , 2016, JCI insight.
[8] W. Hahn,et al. BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers , 2014, Nucleic acids research.
[9] O. Hes,et al. Large cell calcifying Sertoli cell tumor: a clinicopathologic study of 1 malignant and 3 benign tumors using histomorphology, immunohistochemistry, ultrastructure, comparative genomic hybridization, and polymerase chain reaction analysis of the PRKAR1A gene. , 2010, Human pathology.
[10] G. MacLennan,et al. Large cell calcifying Sertoli cell tumor of testis. , 2007, The Journal of urology.
[11] M. Amin,et al. Intratubular Large Cell Hyalinizing Sertoli Cell Neoplasia of the Testis: A Report of 8 Cases of a Distinctive Lesion of the Peutz-Jeghers Syndrome , 2007, The American journal of surgical pathology.
[12] J. Bertherat,et al. Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2. , 2003, Human molecular genetics.
[13] C. Stratakis. Mutations of the Gene Encoding the Protein Kinase A Type I‐α Regulatory Subunit (PRKAR1A) in Patients with the “Complex of Spotty Skin Pigmentation, Myxomas, Endocrine Overactivity, and Schwannomas” (Carney Complex) , 2002, Annals of the New York Academy of Sciences.
[14] J. Srigley,et al. Large cell calcifying Sertoli cell tumor of the testis: contrasting features of six malignant and six benign tumors and a review of the literature. , 1997, The American journal of surgical pathology.
[15] H. Manzanilla-García,et al. Large-cell calcifying Sertoli cell tumor , 2005 .